Intimate Partner Violence and HIV Sexual Risk Behaviour Among Women Who Inject Drugs in Indonesia: A Respondent-Driven Sampling Study

被引:12
|
作者
Stoicescu, Claudia [1 ]
Cluver, Lucie D. [1 ,2 ]
Spreckelsen, Thees [1 ]
Casale, Marisa [1 ,3 ]
Sudewo, Anindita Gabriella [4 ,5 ]
Irwanto [4 ]
机构
[1] Univ Oxford, Dept Social Policy & Intervent, Ctr Evidence Based Intervent, Barnett House,32 Wellington Sq, Oxford, England
[2] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa
[3] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa
[4] Atma Jaya Catholic Univ, HIV & AIDS Res Ctr, Jakarta, Indonesia
[5] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia
基金
加拿大健康研究院;
关键词
Intimate partner violence; HIV; Sexual risk behavior; Women; Injecting drug use; Respondent-driven sampling; CONFLICT-TACTICS-SCALES; SUBSTANCE-ABUSE; TRANSMITTED-DISEASES; INVOLVED WOMEN; USERS; PREVENTION; SEROSTATUS; KNOWLEDGE; HEALTH; METHAMPHETAMINE;
D O I
10.1007/s10461-018-2186-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Women who inject drugs are disproportionately affected by HIV and intimate partner violence (IPV); however, the link between IPV and HIV remains under-researched among substance-using women in low- and middle-income countries. This study examined associations and additive effects of different forms of IPV victimization (psychological, physical and/or injurious, and sexual) on HIV sexual risk behavior among women who inject drugs in Indonesia. Respondent-driven sampling (RDS) was used to recruit 731 women from Greater Jakarta and Bandung, West Java. RDS-II weighted prevalence of any past-year IPV was 68.9% (95% CI 65.0, 72.6) in Jakarta and 55.9% (95% CI 48.0, 63.5) in Bandung. In separate logistic regressions controlling for socio-demographic covariates, all three forms of IPV showed statistically significant associations with sexual risk behavior. After adjusting for all IPV types, psychological (OR 1.87; 95% CI 1.17, 2.99; p=0.009) and sexual (OR 1.98; 95% CI 1.22, 3.21; p=0.006) IPV independently predicted women's sexual risk behavior. Marginal effects models suggested that co-occurrence of multiple forms of IPV had greater adverse consequences: sexual risk behavior was reported by 64.1% of women who did not experience any IPV, but increased to 89.9% among women exposed to all three types. Comprehensive harm reduction services that integrate IPV monitoring and prevention are urgently neededto reduce both HIV and IPV.
引用
收藏
页码:3307 / 3323
页数:17
相关论文
共 50 条
  • [41] Sexual mixing and the risk environment of sexually active transgender women: data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010
    Wilson, Erin C.
    Santos, Glen-Milo
    Raymond, H. Fisher
    BMC INFECTIOUS DISEASES, 2014, 14
  • [42] Sexual mixing and the risk environment of sexually active transgender women: data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010
    Erin C Wilson
    Glen-Milo Santos
    H Fisher Raymond
    BMC Infectious Diseases, 14
  • [43] Reduced bias for respondent-driven sampling: accounting for non-uniform edge sampling probabilities in people who inject drugs in Mauritius
    Ott, Miles Q.
    Gile, Krista J.
    Harrison, Matthew T.
    Johnston, Lisa G.
    Hogan, Joseph W.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2019, 68 (05) : 1411 - 1429
  • [44] Risky sexual networks and concentrated HIV epidemics among men who have sex with men in Wenzhou, China: a respondent-driven sampling study
    Qiaoqin Ma
    Shidian Zeng
    Shichang Xia
    Xiaohong Pan
    Dayong Wang
    Haishen Zhu
    Hui Wang
    Tingting Jiang
    Lin He
    Dongshe Zhao
    Zhihang Peng
    BMC Public Health, 15
  • [45] Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil
    Grinsztejn, Beatriz
    Jalil, Emilia M.
    Monteiro, Laylla
    Velasque, Luciane
    Moreira, Ronaldo I.
    Garcia, Ana Cristina F.
    Castro, Cristiane V.
    Kruger, Alcia
    Luz, Paula M.
    Liu, Albert Y.
    McFarland, Willi
    Buchbinder, Susan
    Veloso, Valdilea G.
    Wilson, Erin C.
    LANCET HIV, 2017, 4 (04): : E169 - E176
  • [46] Risky sexual networks and concentrated HIV epidemics among men who have sex with men in Wenzhou, China: a respondent-driven sampling study
    Ma, Qiaoqin
    Zeng, Shidian
    Xia, Shichang
    Pan, Xiaohong
    Wang, Dayong
    Zhu, Haishen
    Wang, Hui
    Jiang, Tingting
    He, Lin
    Zhao, Dongshe
    Peng, Zhihang
    BMC PUBLIC HEALTH, 2015, 15
  • [47] Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India
    McFall, Allison M.
    Solomon, Sunil S.
    Lau, Bryan
    Latkin, Carl
    Srikrishnan, Aylur K.
    Anand, Santhanam
    Vasudevan, Canjeevaram K.
    Kumar, Muniratnam Suresh
    Lucas, Gregory M.
    Mehta, Shruti H.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 249
  • [48] Testing key underlying assumptions of respondent-driven sampling within a real-world network of people who inject drugs
    Buchanan, Ryan M.
    Cook, Charlotte
    Khakoo, Salim I.
    Parkes, Julie
    INTERNATIONAL JOURNAL OF SOCIAL RESEARCH METHODOLOGY, 2022, 25 (01) : 91 - 102
  • [49] Assessing reliability of naïve respondent-driven sampling samples by using repeated surveys among people who inject drugs (PWID) in New Jersey
    Wang, Peng
    Wogayehu, Afework
    Bolden, Barbara
    Ibrahim, Abdel R.
    Raymond, Henry F.
    ANNALS OF EPIDEMIOLOGY, 2024, 94 : 100 - 105
  • [50] High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)
    Benjamin Wenz
    Stine Nielsen
    Martyna Gassowski
    Claudia Santos-Hövener
    Wei Cai
    R. Stefan Ross
    Claus-Thomas Bock
    Boris-Alexander Ratsch
    Claudia Kücherer
    Norbert Bannert
    Viviane Bremer
    Osamah Hamouda
    Ulrich Marcus
    Ruth Zimmermann
    BMC Public Health, 16